These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16731104)

  • 1. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies.
    Jaggers J; Lawson JH
    Ann Thorac Surg; 2006 Jun; 81(6):S2360-6. PubMed ID: 16731104
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiopulmonary bypass-associated coagulopathies and prophylactic therapy.
    Maslow A; Schwartz C
    Int Anesthesiol Clin; 2004; 42(3):103-33. PubMed ID: 15205643
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction.
    Day JR; Landis RC; Taylor KM
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):132-42. PubMed ID: 16959740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
    Wan S; LeClerc JL; Vincent JL
    Chest; 1997 Sep; 112(3):676-92. PubMed ID: 9315800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory response and haematological disorders in cardiac surgery: toward a more physiological cardiopulmonary bypass].
    Baufreton C; Corbeau JJ; Pinaud F
    Ann Fr Anesth Reanim; 2006 May; 25(5):510-20. PubMed ID: 16488106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of coagulopathy in cardiac surgery: an update.
    Rozental T; Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):669-79. PubMed ID: 22608465
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation considerations for infants and children undergoing cardiopulmonary bypass.
    Eaton MP; Iannoli EM
    Paediatr Anaesth; 2011 Jan; 21(1):31-42. PubMed ID: 21155925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation and cardiac surgery: an update.
    Asimakopoulos G
    Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiopulmonary bypass coagulopathy in a neonate with a family history of von Willebrand disease.
    Ullah S; Schmitz ML; Stine KC; Johnson CE; Faulkner SC; Drummond-Webb JJ
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):576-9. PubMed ID: 16884994
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterizing the inflammatory response to cardiopulmonary bypass in children.
    Kozik DJ; Tweddell JS
    Ann Thorac Surg; 2006 Jun; 81(6):S2347-54. PubMed ID: 16731102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors?
    Murkin JM
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2 Suppl 1):19-23; discussion 24-5. PubMed ID: 9106010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
    Holcomb JB; Hoots K; Moore FA
    Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood conservation in liver transplantation: The role of aprotinin.
    Porte RJ; Hendriks HG; Slooff MJ
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):31S-37S. PubMed ID: 15368204
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass.
    Ferreira CA; Vicente WV; Evora PR; Rodrigues AJ; Klamt JG; Carlotti AP; Carmona F; Manso PH
    Rev Bras Cir Cardiovasc; 2010; 25(1):85-98. PubMed ID: 20563473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coagulopathy of cardiopulmonary bypass.
    Besser MW; Klein AA
    Crit Rev Clin Lab Sci; 2010 Dec; 47(5-6):197-212. PubMed ID: 21391830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of circuit miniaturization in reducing inflammatory response to infant cardiopulmonary bypass by elimination of allogeneic blood products.
    Hickey E; Karamlou T; You J; Ungerleider RM
    Ann Thorac Surg; 2006 Jun; 81(6):S2367-72. PubMed ID: 16731105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.